Franklin Limited Duration Income Trust Announces Expiration of Tender Offer
Mar 06, 2017 13:32 pm UTC| Business
SAN MATEO, Calif., March 06, 2017 -- Franklin Limited Duration Income Trust (NYSE MKT:FTF), a closed-end investment company managed by Franklin Advisers, Inc., announced today the preliminary results of its tender offer...
Franklin Limited Duration Income Trust Announces Expiration of Tender Offer
Mar 06, 2017 13:32 pm UTC| Business
SAN MATEO, Calif., March 06, 2017 -- Franklin Limited Duration Income Trust (NYSE MKT:FTF), a closed-end investment company managed by Franklin Advisers, Inc., announced today the preliminary results of its tender offer...
Mar 06, 2017 13:32 pm UTC| Business
COEUR DALENE, Idaho, March 06, 2017 -- New Jersey Mining Company (OTCQB:NJMC) (“NJMC” or the “Company”) is pleased to announce it has closed its $427,500 private placement and has submitted an application for listing...
Mar 06, 2017 13:32 pm UTC| Business
COEUR DALENE, Idaho, March 06, 2017 -- New Jersey Mining Company (OTCQB:NJMC) (“NJMC” or the “Company”) is pleased to announce it has closed its $427,500 private placement and has submitted an application for listing...
Mar 06, 2017 13:32 pm UTC| Business
COEUR DALENE, Idaho, March 06, 2017 -- New Jersey Mining Company (OTCQB:NJMC) (“NJMC” or the “Company”) is pleased to announce it has closed its $427,500 private placement and has submitted an application for listing...
Galectin’s GR-MD-02 Demonstrates Efficacy in Patients with Moderate to Severe Plaque Psoriasis
Mar 06, 2017 13:31 pm UTC| Business
Research done in partnership with San Antonio Military Medical Center showed an average 50% PASI reduction by end of 24-week treatment period NORCROSS, Ga., March 06, 2017 -- Galectin Therapeutics Inc. (NASDAQ:GALT),...
Galectin’s GR-MD-02 Demonstrates Efficacy in Patients with Moderate to Severe Plaque Psoriasis
Mar 06, 2017 13:31 pm UTC| Business
Research done in partnership with San Antonio Military Medical Center showed an average 50% PASI reduction by end of 24-week treatment period NORCROSS, Ga., March 06, 2017 -- Galectin Therapeutics Inc. (NASDAQ:GALT),...